Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 110.05 0.31 (0.28%) Market Cap: 6.94 Bil Enterprise Value: 10.91 Bil PE Ratio: 22.69 PB Ratio: 1.88 GF Score: 78/100

Jazz Pharmaceuticals PLC to Acquire GW Pharmaceuticals PLC Call Transcript

Feb 03, 2021 / 01:30PM GMT
Release Date Price: $151.21 (-3.87%)
Operator

Welcome to Jazz Pharmaceuticals Investor Update Conference Call. (Operator Instructions) I will now turn the call over to Andrea Flynn, Vice President and Head of Investor Relations at Jazz Pharmaceuticals.

Andrea Flynn

Thank you, and good morning, everyone. Thanks for joining our call today to discuss Jazz's acquisition of GW Pharmaceuticals. Joining me today are Bruce Cozadd, our Co-Founder, Chairman and CEO; Renée Galá, our CFO; and Justin Gover, CEO of GW Pharmaceuticals. Jazz's President, Dan Swisher and Executive Vice President of R&D, Rob Iannone as well as GW's CFO, Scott Giacobello, will join for Q&A.

As a reminder, this call is being recorded and a press release and slide presentation regarding today's news are available on the Investor Relations section of Jazz and GW's respective website. This communication is not intended to constitute an offer to buy or sell or the solicitation of an offer to buy any securities, or solicitation of any vote or approval. GW intends to file a proxy statement with the SEC regarding the proposed transaction

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot